A pilot study of Cutimed<sup>®</sup> Sorbact</sup>®</sup> versus ACTICOAT™ versus Silverlon<sup>®</sup> for the treatment of burn wounds in a South African adult burn unit
AbstractBackground: Since significant clinical data are unavailable on the use of Cutimed® Sorbact® in burns, a decision was taken to test it against the best anti-infective dressings used in our burns unit. Method: A random prospective study was conducted in which Cutimed® Sorbact® was compared with control products, ACTICOAT™ and Silverlon®. Selected patients had partial- or full-thickness burns. Results: Thirteen patients were included in the pilot study. Fifty-seven dressing areas were tested. A statistical difference between the tested product and the control products was not found through either clinical observation or microbiological analysis. Conclusion: This pilot study confirmed that the Cutimed® Sorbact® dressing was safe when treating burn wounds over a three-day period. In addition, the potential to use it on earlier or fresher burn wounds warrants the further study of Cutimed® Sorbact® as a potential skin substitute.
Wound care/Stoma care
By submitting manuscripts to PNT, authors of original articles are assigning copyright to Medpharm Publications (Pty) Ltd. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in PNT for educational and research purposes without obtaining permission.